{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:09:01Z","timestamp":1789366141121,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd004772.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:00:00Z","timestamp":1400716800000}}],"reference-count":75,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004772.pub4","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T19:36:36Z","timestamp":1400787396000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age"],"prefix":"10.1002","volume":"2014","author":[{"given":"Martina","family":"Penazzato","sequence":"first","affiliation":[{"name":"MRC Clinical Trials Unit; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Prendergast","sequence":"additional","affiliation":[{"name":"Queen Mary University of London; Centre for Paediatrics, Blizard Institute; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu M","family":"Muhe","sequence":"additional","affiliation":[{"name":"World Health Organization; 20 Avenue Appia Geneva Switzerland 1211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Tindyebwa","sequence":"additional","affiliation":[{"name":"African Network for the Care of Children Affected by HIV\/AIDS (ANECCA); Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Abrams","sequence":"additional","affiliation":[{"name":"Columbia University. Mailman School of Public Health; Epidemiology and Pediatrics; 722 W 168th St New York New York USA 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"10.1002\/14651858.CD004772.pub4-BIB0001|cit1","unstructured":"Achan j Kahuru A Ikilezi G Ruel T Clark T Charlebois E Rosenthal P Dorsey G Havlir D Kamya M Significant Reduction in Risk of Malaria among HIV + \u00a0Children Receiving Lopinavir\/ritonavir-based ART Compared to NNRTI-based ART, a Randomized Open-label Trial March 2012"},{"issue":"12","key":"10.1002\/14651858.CD004772.pub4-BIB0002|cit2","first-page":"62198","article-title":"Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in Africanchildren with HIV (ARROW): a 5-year open-label randomised factorial trial","volume":"370","author":"ARROW Trial team","journal-title":"Lancet. 2013"},{"issue":"10","key":"10.1002\/14651858.CD004772.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.2010.1278","article-title":"Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomised controlled trial","volume":"304","author":"Coovadia","year":"2010","journal-title":"JAMA"},{"issue":"16","key":"10.1002\/14651858.CD004772.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure","volume":"363","author":"Palumbo","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1002\/14651858.CD004772.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0b013e32830437df","article-title":"Early virological suppression with three-class antiretroviral therapy in HIV-infected AFrican infants","volume":"22","author":"Prendergast","year":"2008","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early Antiretroviral Therapy and Mortality among HIV-Infected Infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0007|cit7","unstructured":"Violari\u00a0A \u00a0Lindsey JC \u00a0Hughes MD \u00a0Mujuru HA \u00a0Barlow-Mosha L \u00a0Kamthunzi P \u00a0Chi BH \u00a0Cotton MF \u00a0Moultrie H \u00a0Khadse S \u00a0Schimana W \u00a0Bobat R \u00a0Purdue L Eshleman SH \u00a0Abrams EJ \u00a0Millar L \u00a0Petzold E \u00a0Mofenson LM \u00a0Jean-Philippe P \u00a0Palumbo P NVP- vs LPV\/r-based ART among HIV+ Infants in Resource-limited Settings: The IMPAACT P1060 Trial N Engl J Med 2380 9"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0008|cit8","unstructured":"Wamalwa D Benki-Nugent S Langat A Tapia K Ngugi E Moraa H Otieno V Richardson B Overbaugh J John-Stewart G 19th Conference on Retroviruses and Opportunistic Infections- Seattle, Washington State (US) March, 2012"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-6405-5-24","article-title":"A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection","volume":"5","author":"Ananworanich","year":"2008","journal-title":"AIDS Res Ther"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0010|cit10","unstructured":"Cotton M Violari A Gibb G Otwombe K Josipovic D Panchia R Jean-Philippe P Handelsman E McIntyre J Babiker A and the CHER Team Early ART followed by Interruption Is Safe and Is Associated with Better Outcomes than Deferred ART in HIV + \u00a0Infants: Final Results from the 6-Year Randomized CHER Trial, South Africa CROI 2012 March 2012"},{"issue":"10","key":"10.1002\/14651858.CD004772.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/01.inf.0000180508.21918.8a","article-title":"Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403","volume":"24","author":"King","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1002\/14651858.CD004772.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/338814","article-title":"Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1","volume":"34","author":"Krogstad","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1002\/14651858.CD004772.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa062876","article-title":"Response to antiretroviral therapy after a single, peripartum dose of nevirapine","volume":"356","author":"Lockman","year":"2007","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1002\/14651858.CD004772.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa032706","article-title":"A trial of three antiretroviral regimens in HIV-1-infected children","volume":"350","author":"Luzuriaga","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0015|cit15","unstructured":"John-Stewart G Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya Clinicaltrials.gov"},{"issue":"4","key":"10.1002\/14651858.CD004772.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(10)70313-3","article-title":"First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2\/3 trial","volume":"11","author":"The PENPACT-1 (PENTA 9\/PACTG 390) Study Team","year":"2011","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0017|cit17","article-title":"Randomized controlled trial of 3 approaches to management of HIV-infected infants","volume":"Abstract 77LB","author":"Prendergast","journal-title":"16th Conferences on Retroviruses and Opportunistic Infections, Boston, Massachusetts, USA Canada"},{"issue":"12","key":"10.1002\/14651858.CD004772.pub4-BIB0018|cit18","first-page":"70242","article-title":"Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre,randomised, open-label trial","volume":"S1473-3099","author":"Puthanakit","journal-title":"The Lancet ID"},{"issue":"12","key":"10.1002\/14651858.CD004772.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1089\/088922200414956","article-title":"Combination nucleoside analogue reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team","volume":"16","author":"Wiznia","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"10.1002\/14651858.CD004772.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/INF.0b013e3181e0554c","article-title":"CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus-infected children","volume":"29","author":"Wongsawat","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0021|cit21","article-title":"International phase 2b-3 randomized clinical trial to assess two once-daily simplified antiretroviraltriple therapies among HIV-infected children early treated by a 12-month twice daily triple therapybetween 6 weeks and 24 months of age and in virological success in Africa:the MONOD Project(Burkina Faso, Ivory Coast, Rwanda)","author":"Leroy","journal-title":"clinicaltrial.gov NCT01127204"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0022|cit22","unstructured":"Treatment Options for Protease Inhibitor-exposed Children (NEVEREST-III) Ongoing study"},{"issue":"1","key":"10.1002\/14651858.CD004772.pub4-BIB0023|cit23","first-page":"97","article-title":"Epidemiology and Social Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis","volume":"22","author":"Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0024|cit24","unstructured":"Apollo T Zinyowera S Dzangare J Chakanyuka C Mugurungi O Penazzato M Martin E Jordan M Perriens J Bertagnolio S 7th IAS Conference in HIV pathogenesis. treatment and prevention. Luala Lumpur, Malaysia"},{"issue":"1","key":"10.1002\/14651858.CD004772.pub4-BIB0025|cit25","first-page":"39","article-title":"Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy","volume":"32","author":"Arpadi","year":"2013","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD004772.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ije\/dym104","article-title":"Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.","volume":"36","author":"Arriv\u00e9","year":"2007 Oct","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1002\/14651858.CD004772.pub4-BIB0027|cit27","first-page":"2458","article-title":"Implementing services for Early Infant Diagnosis (EID) of HIV: a comparative descriptive analysis of national programs in four countries","volume":"533","author":"Chatterjee","year":"2010","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1002\/14651858.CD004772.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/aid.2009.0003","article-title":"In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.","volume":"25","author":"Church","year":"2009 Jul","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0029|cit29","unstructured":"Department of Health and Human Services Antiretroviral Therapy and Medical Management of HIV- Infected Children 2011"},{"issue":"3","key":"10.1002\/14651858.CD004772.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/524686","article-title":"Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults.","volume":"197","author":"Dunn","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1002\/14651858.CD004772.pub4-BIB0031|cit31","first-page":"2279","article-title":"Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens","volume":"25","author":"The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord","journal-title":"AIDS"},{"issue":"15","key":"10.1002\/14651858.CD004772.pub4-BIB0032|cit32","first-page":"2039","article-title":"AIDS among older children and adolescents inSouthern Africa: projecting the time course and magnitude of the epidemic.","volume":"23","author":"Ferrand","journal-title":"AIDS. 2009"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0033|cit33","unstructured":"Fillekes Q Mulenga V Kabamba D Kankasa C Thomason MJ Cook A Chintu C Gibb DM Walker AS Burger DM on behalf of the CHAPAS-1 trial team + AIDS"},{"issue":"21","key":"10.1002\/14651858.CD004772.pub4-BIB0034|cit34","first-page":"1522","article-title":"Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1","volume":"345","author":"Gortmaker","journal-title":"N Engl J Med. 2001"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0035|cit35","first-page":"pp. 5\u201344","article-title":"The Abilities of Babies","author":"Griffiths","year":"1976","journal-title":"University of London Press; A study in mental measurement"},{"issue":"9849","key":"10.1002\/14651858.CD004772.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","author":"Gupta","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0037|cit37","volume-title":"Cochrane handbook for systematic reviews of interventions, version 5.1.0","author":"Higgins","year":"March 2011"},{"issue":"9396","key":"10.1002\/14651858.CD004772.pub4-BIB0038|cit38","first-page":"1605","article-title":"Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis.","volume":"362","author":"Dunn","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD004772.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e3283492180","article-title":"HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine","volume":"25","author":"Hunt","journal-title":"AIDS"},{"issue":"8","key":"10.1002\/14651858.CD004772.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00002030-199905280-00008","article-title":"Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy.","volume":"13","author":"The Italian Register for HIV Infection in","year":"1999","journal-title":"AIDS"},{"issue":"14","key":"10.1002\/14651858.CD004772.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","article-title":"Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children","volume":"14","author":"Jaquet","journal-title":"AIDS"},{"issue":"5","key":"10.1002\/14651858.CD004772.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.qai.0000225871.87456.e7","article-title":"Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State","volume":"42","author":"Karchava","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0b013e3182755a34","article-title":"Prevalence of Lipodystrophy in HIV-Infected Children in Tanzania on HAART","volume":"32","author":"Kinabo","year":"2013","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0044|cit44","unstructured":"Kuhn L Coovadia A Strehlau R Meyers T Martens L Sherman G Hunt G Tsai W-T Morris L Ambrams E Long-term Outcomes of Switching Children to NVP-based Therapy after Initial Suppression with a PI-based Regimen"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0045|cit45","unstructured":"Kuhn L Hunt G Technau K Coovadia A Black V Morris L Abrams E. and Finding Infants with HIV Disease and Evaluating Resistance Study Group + 20th Conference on Retroviruses and Opportunistic Infections- Atlanta, Georgia"},{"issue":"13","key":"10.1002\/14651858.CD004772.pub4-BIB0046|cit46","first-page":"1685","article-title":"Early antiretroviral therapy improves neurodevelopmental outcomes in infants","volume":"24","author":"Laughton\u00a0B","journal-title":"AIDS"},{"issue":"4","key":"10.1002\/14651858.CD004772.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/infdis\/jir787","article-title":"Age and CD4 count at initiation of antiretroviral therapy in\u00a0HIV-infected children: effects on long-term T-cell reconstitution.","volume":"205","author":"Lewis","journal-title":"J Infect Dis"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0048|cit48","unstructured":"Lindsey J Hughes M A Violari Eshleman S Abrams E Mofenson L Jean-Philippe P Palumbo P and P1060 Study Team\u00a0 Predictors of Virologic and Clinical Response to Nevirapine- vs Lopinavir\/ritonavir-based ART in Infants and Children with and without Prior Nevirapine Exposure for the PMTCT CROI 2012 March 2012"},{"issue":"356","key":"10.1002\/14651858.CD004772.pub4-BIB0049|cit49","first-page":"135","article-title":"Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine","author":"Lockman","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"73\u201383","DOI":"10.1046\/j.1365-2214.2001.00158.x","article-title":"The construct validity of the Griffiths Scales of Infant Development.","volume":"27","author":"Luiz","year":"2001","journal-title":"Child: care health and development."},{"issue":"2","key":"10.1002\/14651858.CD004772.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31802b920e","article-title":"J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):148-53.Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.","volume":"44","author":"Martinson","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1002\/14651858.CD004772.pub4-BIB0052|cit52","first-page":"140","article-title":"Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.","volume":"4","author":"McComsey","year":"2002 Jul-Sep","journal-title":"AIDS Rev"},{"issue":"12","key":"10.1002\/14651858.CD004772.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00006454-199612000-00006","article-title":".Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus","volume":"15","author":"McIntosh","year":"1996 Dec","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1002\/14651858.CD004772.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/QAD.0b013e3281a3bec2","article-title":"High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.","volume":"21","author":"Mphatswe","year":"2007","journal-title":"AIDS"},{"issue":"9","key":"10.1002\/14651858.CD004772.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/656628","article-title":"Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination \"baby pills\" in Zambia: a randomized controlled trial.","volume":"51","author":"Mulenga","journal-title":"Clin Infect Dis."},{"issue":"10","key":"10.1002\/14651858.CD004772.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/aid.2009.0054","article-title":"Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine","volume":"25","author":"Musiime","year":"2009 Oct","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9441","key":"10.1002\/14651858.CD004772.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.","volume":"364","author":"Newell","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0058|cit58","unstructured":"United States National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS, Table for Grading Adult and Pediatric Adverse Events (Toxicity Table),dated December 2004 (Clarification August 2009)"},{"issue":"2","key":"10.1002\/14651858.CD004772.pub4-BIB0059|cit59","first-page":"231","article-title":"Response to planned treatment interruptions in HIV infection varies across childhood","volume":"24","author":"Paediatric European Network for Treatment of AIDS","journal-title":"AIDS"},{"issue":"359(9308)","key":"10.1002\/14651858.CD004772.pub4-BIB0060|cit60","first-page":"733","article-title":"Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial","volume":"2","author":"Paediatric European Network for Treatment of AIDS (PENTA)","year":"2002 Mar","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD004772.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1468-1293.2009.00759.x","article-title":"PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection.","volume":"10","author":"PENTA Steering Committee","year":"2009","journal-title":"HIV Medicine"},{"issue":"10","key":"10.1002\/14651858.CD004772.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/513871","article-title":"Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.","volume":"195","author":"Persaud","journal-title":"J Infect Dis"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0063|cit63","unstructured":"Persaud D Gay H Ziemniak C Chen YH Piatak M Chun TW Strain M Richman D Luzuriaga K Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant. N Engl J Med."},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004772.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135965350801302S09","article-title":"Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004","volume":"13","author":"Pillay","year":"2008","journal-title":"Antivir Ther. ;"},{"issue":"2","key":"10.1002\/14651858.CD004772.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"17427","DOI":"10.7448\/IAS.15.2.17427","article-title":"Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.","volume":"15","author":"Piloya","year":"2012","journal-title":"Journal of the International AIDS Society"},{"issue":"7","key":"10.1002\/14651858.CD004772.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"e1001273","DOI":"10.1371\/journal.pmed.1001273","article-title":"Treatment of young children with HIV infection: using evidence to inform policymakers","volume":"9","author":"Prendergast","year":"2012","journal-title":"PLoS Med"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0067|cit67","unstructured":"Ruel T Kakuru A Ikilezi G Mwangwa F Dorsey G Rosenthal P Charlebois E Havlir D Kamya M Achan J 20th Conference on Retroviruses and Opportunistic Infections- Atlanta, Georgia, USA."},{"key":"10.1002\/14651858.CD004772.pub4-BIB0068|cit68","article-title":"UNAIDS Report on the global AIDS epidemIc 2012","author":"UNAIDS","year":"2012","journal-title":"http:\/\/www.unaids.org\/en\/resources\/campaigns\/20121120_globalreport2012\/globalreport\/"},{"issue":"5","key":"10.1002\/14651858.CD004772.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","article-title":"Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children","volume":"32","author":"Vigan\u00f2","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"22","key":"10.1002\/14651858.CD004772.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/sim.4780132207","article-title":"Age-related reference ranges: significance tests for models and confidence intervals for centiles","volume":"13","author":"Wade","journal-title":"Stat Med"},{"issue":"14","key":"10.1002\/14651858.CD004772.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00002030-200409240-00007","article-title":"Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study","volume":"18","author":"Walker","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0072|cit72","unstructured":"WHO Antiretroviral therapy for HIV infection in infants and children: Recommendations for a public health approach (2010 revision) 2010"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0073|cit73","unstructured":"WHO 2011 GLOBAL HIV\/AIDS RESPONSE. Epidemic update and health sector progress towards Universal Access. Progress Report 2011"},{"key":"10.1002\/14651858.CD004772.pub4-BIB0074|cit74","unstructured":"World Health Organisation Consolidated Guidelines on the use of Antiretroviral drugs for treating and preventing HIVinfection June 2013"},{"issue":"7","key":"10.1002\/14651858.CD004772.pub4-BIB0075|cit75","article-title":"Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age","author":"Penazzato","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004772.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T09:59:26Z","timestamp":1713347966000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004772.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":75,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004772.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}